BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2497245)

  • 1. Ovulation induction for assisted reproduction.
    Scott RT; Rosenwaks Z
    J Reprod Med; 1989 Jan; 34(1 Suppl):108-14. PubMed ID: 2497245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
    Andersen CY; Humaidan P; Ejdrup HB; Bungum L; Grøndahl ML; Westergaard LG
    Hum Reprod; 2006 Aug; 21(8):2126-30. PubMed ID: 16682403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer].
    Xu SR; Li Y; Liu H; Li HY; Tang R; Gao Q; Sheng Y; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):420-3. PubMed ID: 21029591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled ovarian hyperstimulation for the new reproductive technologies.
    Navot D; Sandler B
    Acta Eur Fertil; 1989; 20(4):217-21. PubMed ID: 2519574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
    Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S
    Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of purified FSH in female infertility].
    Antoine JM; Salat-Baroux J
    Contracept Fertil Sex; 1993 Apr; 21(4):301-6. PubMed ID: 7951630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New trends in combined use of gonadotropin-releasing hormone antagonists with gonadotropins or pulsatile gonadotropin-releasing hormone in ovulation induction and assisted reproductive technologies.
    Gordon K; Danforth DR; Williams RF; Hodgen GD
    Curr Opin Obstet Gynecol; 1992 Oct; 4(5):690-6. PubMed ID: 1391640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
    Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
    Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovulation induction in women in the in vitro fertilization program].
    Vuleta D; Begenisić M
    Med Pregl; 1996; 49(11-12):497-500. PubMed ID: 9019636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian stimulation: a new approach based on recent physiological and clinical data. Future perspectives].
    Lunenfeld B
    Contracept Fertil Sex; 1993 Apr; 21(4 Suppl):1-7. PubMed ID: 7951638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
    Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. 1. FSH and LH profiles].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1987; 109(24):1478-92. PubMed ID: 3126616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J; Quigley MM
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oocyte retrieval for in vitro fertilization.
    Diedrich K; Van der Ven H; Al-Hasani S; Werner A; Krebs D
    Ann Biol Clin (Paris); 1987; 45(3):351-7. PubMed ID: 2959179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.